Quarterly Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7344479

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
25,986,000,000 JPY
39,363,000,000 JPY
Interest and dividends received
754,000,000 JPY
572,000,000 JPY
Interest paid
-22,000,000 JPY
-18,000,000 JPY
Income taxes paid
-8,358,000,000 JPY
-8,003,000,000 JPY
Net cash provided by (used in) operating activities
18,360,000,000 JPY
31,914,000,000 JPY
Cash flows from investing activities
Purchase of securities
-4,000,000,000 JPY
-2,000,000,000 JPY
Purchase of property, plant and equipment
-12,756,000,000 JPY
-14,747,000,000 JPY
Proceeds from sale of property, plant and equipment
5,000,000 JPY
3,000,000 JPY
Purchase of investment securities
-220,000,000 JPY
-19,000,000 JPY
Proceeds from sale of investment securities
531,000,000 JPY
45,000,000 JPY
Other, net
-231,000,000 JPY
-253,000,000 JPY
Net cash provided by (used in) investing activities
-19,576,000,000 JPY
-14,312,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-12,000,000,000 JPY
-14,056,000,000 JPY
Dividends paid
-7,223,000,000 JPY
-6,509,000,000 JPY
Other, net
-239,000,000 JPY
-191,000,000 JPY
Net cash provided by (used in) financing activities
-19,463,000,000 JPY
-20,759,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
890,000,000 JPY
673,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-19,789,000,000 JPY
-2,484,000,000 JPY
Cash and cash equivalents
59,690,000,000 JPY
79,480,000,000 JPY
81,987,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.